Proton/Photon Rt - Benign Meningiomas(P92-13)

Completed · Phase 3

Conditions studied: Benign Meningioma

In brief

The purpose of this study is to determine the best radiation dose for participants with meningioma that has grown back after previous surgery, or which the surgeon has been unable to remove completely. This research study is designed to determine whether a higher dose of radiation will decrease the likelihood that the tumor will grow back, compared to the probability of re-growth that occurs after standard radiation doses.

Key facts

Study ID

NCT02947984

Run by

Massachusetts General Hospital

People needed

44

Starts

1999-03-01

Expected to finish

2016-09-01

Last updated by the study team

2017-06-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 or over
• Histological documentation of benign meningioma
• Documentation by imaging studies (CT and/ or MRI) or residual or recurrent intracranial tumor
• Karnofsky performance status of ≥ 70
• Study specific informed consent

You may not qualify if…

• Malignant meningiomas
• Prior cranial irradiation, except treatment of localized skin cancer of the face or scalp
• Patients having a concurrent primary cancer (except skin)
• Patients having another cancer controlled < 3 years
• Pregnant patients

Where it is running

• Massachusetts General Hosital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.